$CLOQ
CYBERLOQ TECHNOLOGIES, INC. Stock $cloq

$cloq Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223026787 Filed on August 04, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue			$1.104K
YoY Change			17.57%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.937K	$4.782K	$7.187K
YoY Change	-11.11%	-33.46%	103.37%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$81.42K	$93.47K	$190.5K
YoY Change	-27.73%	-50.95%	-3.61%
Operating Profit	-$81.42K	-$93.47K	-$189.4K
YoY Change	-26.63%	-50.66%	-4.2%
Interest Expense	-$201.3K	-$120.3K	-$58.36K
YoY Change	2838.39%	106.07%	1015.87%
% of Operating Profit
Other Income/Expense, Net	-$201.3K	-$120.3K	-$163.4K
YoY Change	2839.18%	-26.38%	3024.13%
Pretax Income	-$282.7K	-$213.7K	-$352.8K
YoY Change	139.92%	-39.42%	74.68%
Income Tax
% Of Pretax Income
Net Earnings	-$282.7K	-$213.7K	-$352.8K
YoY Change	139.92%	-39.42%	74.68%
Net Earnings / Revenue			-31957.07%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$4.077K
COMMON SHARES
Basic Shares Outstanding	120.4M shares	119.7M shares
Diluted Shares Outstanding	121.1M shares	120.8M shares	86.54M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.80K	$23.36K	$16.81K
YoY Change	18.44%	38.96%	-82.91%
Cash & Equivalents	$45.80K	$23.36K	$16.81K
Short-Term Investments
Other Short-Term Assets	$21.38K	$79.40K	$19.78K
YoY Change	-65.25%	301.42%	-95.85%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$67.17K	$102.8K	$36.60K
YoY Change	-32.95%	180.79%	-93.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$838.2K	$589.9K	$136.6K
YoY Change	295.83%	331.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$838.2K	$589.9K	$136.6K
YoY Change	295.83%	331.84%
TOTAL ASSETS
Total Short-Term Assets	$67.17K	$102.8K	$36.60K
Total Long-Term Assets	$838.2K	$589.9K	$136.6K
Total Assets	$905.4K	$692.7K	$173.2K
YoY Change	190.24%	299.92%	-69.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$34.32K	$24.67K	$61.97K
YoY Change	-14.29%	-60.19%	-16.27%
Accrued Expenses	$104.3K	$77.20K	$39.02K
YoY Change	127.47%	97.85%	145.1%
Deferred Revenue	$0.00	$0.00	$0.00
YoY Change
Short-Term Debt	$185.0K	$185.0K	$185.0K
YoY Change	37.04%	0.0%	-5.13%
Long-Term Debt Due	$335.6K	$162.0K	$2.090K
YoY Change	15957.42%	7649.28%
Total Short-Term Liabilities	$659.2K	$448.8K	$614.7K
YoY Change	195.63%	-26.99%	115.75%
LONG-TERM LIABILITIES
Long-Term Debt	$30.36K	$30.36K	$81.24K
YoY Change	-76.8%	-62.63%	128.2%
Other Long-Term Liabilities			$163.3K
YoY Change
Total Long-Term Liabilities	$30.36K	$30.36K	$244.6K
YoY Change	-76.8%	-87.59%	586.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$659.2K	$448.8K	$614.7K
Total Long-Term Liabilities	$30.36K	$30.36K	$244.6K
Total Liabilities	$689.6K	$479.2K	$859.3K
YoY Change	94.87%	-44.24%	168.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.886M	-$7.603M	-$6.910M
YoY Change	12.22%	10.04%
Common Stock	$121.1K	$120.9K	$97.67K
YoY Change	10.24%	23.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$50.00K	$50.00K	$50.00K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$215.8K	$213.5K	-$686.1K
YoY Change
Total Liabilities & Shareholders Equity	$905.4K	$692.7K	$173.2K
YoY Change	190.24%	299.92%	-69.91%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$282.7K	-$213.7K	-$352.8K
YoY Change	139.92%	-39.42%	74.68%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$14.27K	-$157.6K	-$88.53K
YoY Change	-91.23%	77.98%	-42.32%
INVESTING ACTIVITIES
Capital Expenditures	$248.3K	$138.0K	-$26.72K
YoY Change	-430.39%	-616.43%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$248.3K	-$138.0K	-$26.72K
YoY Change	230.39%	416.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	285.0K	300.3K	79.45K
YoY Change	9.76%	277.91%	-63.89%
NET CHANGE
Cash From Operating Activities	-14.27K	-157.6K	-88.53K
Cash From Investing Activities	-248.3K	-138.0K	-26.72K
Cash From Financing Activities	285.0K	300.3K	79.45K
Net Change In Cash	22.44K	4.690K	-35.80K
YoY Change	2.65%	-113.1%	-153.83%
FREE CASH FLOW
Cash From Operating Activities	-$14.27K	-$157.6K	-$88.53K
Capital Expenditures	$248.3K	$138.0K	-$26.72K
Free Cash Flow	-$262.6K	-$295.6K	-$61.81K
YoY Change	200.1%	378.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001437517
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ServiceMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ServiceMember
CY2023Q2	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ServiceMember
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q2	CLOQ	Loss On Settlement With Officer LossOnSettlementWithOfficer		usd
CY2022Q2	CLOQ	Loss On Settlement With Officer LossOnSettlementWithOfficer		usd
	CLOQ	Loss On Settlement With Officer LossOnSettlementWithOfficer		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	CLOQ	Loss On Settlement With Officer And Director LossOnSettlementWithOfficerAndDirector		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	CLOQ	Beneficial Conversion Feature BeneficialConversionFeature		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1		usd
	us-gaap	Notes Issued1 NotesIssued1		usd
	CLOQ	Notes Issued NotesIssued		usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2023Q2	CLOQ	Accumulated Impairment Expense AccumulatedImpairmentExpense		usd
CY2022Q4	CLOQ	Accumulated Impairment Expense AccumulatedImpairmentExpense		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-170132
	dei	Entity Registrant Name EntityRegistrantName	CYBERLOQ TECHNOLOGIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity File Number EntityFileNumber	333-170132
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2118480
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4837 Swift Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210-1
	dei	Entity Address City Or Town EntityAddressCityOrTown	Sarasota
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34231
	dei	City Area Code CityAreaCode	612
	dei	Local Phone Number LocalPhoneNumber	961-4536
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CLOQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	120439754	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23359	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4067	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	79397	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	53811	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	102756	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	57878	usd
CY2023Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	589931	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	283240	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	589931	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	283240	usd
CY2023Q2	us-gaap	Assets Assets	692687	usd
CY2022Q4	us-gaap	Assets Assets	341118	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	24666	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56322	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	77202	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	47737	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	159873	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2623	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	2088	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	2088	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	448829	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	293770	usd
CY2023Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	30362	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	30362	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	30362	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	30362	usd
CY2023Q2	us-gaap	Liabilities Liabilities	479191	usd
CY2022Q4	us-gaap	Liabilities Liabilities	324132	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120939754	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120939754	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	119089754	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	119089754	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	120940	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	119090	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	20	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	20	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	50000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	50000	usd
CY2023Q2	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	2450000	shares
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	2450000	shares
CY2023Q2	CLOQ	Shares To Be Issued SharesToBeIssued	149186	usd
CY2022Q4	CLOQ	Shares To Be Issued SharesToBeIssued	149186	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7596712	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7031812	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7603362	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7233122	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	213496	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16986	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	692687	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	341118	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1104	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	993	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1404	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1104	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	993	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1404	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	18489	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	133643	usd
	us-gaap	Professional Fees ProfessionalFees	52308	usd
	us-gaap	Professional Fees ProfessionalFees	340397	usd
CY2023Q2	us-gaap	Officers Compensation OfficersCompensation	45000	usd
CY2022Q2	us-gaap	Officers Compensation OfficersCompensation	45000	usd
	us-gaap	Officers Compensation OfficersCompensation	90000	usd
	us-gaap	Officers Compensation OfficersCompensation	105000	usd
CY2023Q2	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	2157	usd
CY2022Q2	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	691	usd
	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	2713	usd
	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	751	usd
CY2023Q2	CLOQ	Rent Expense RentExpense	2449	usd
CY2022Q2	CLOQ	Rent Expense RentExpense	2332	usd
	CLOQ	Rent Expense RentExpense	4747	usd
	CLOQ	Rent Expense RentExpense	4521	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4782	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7187	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8330	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11637	usd
CY2023Q2	us-gaap	Supplies Expense SuppliesExpense	4232	usd
CY2022Q2	us-gaap	Supplies Expense SuppliesExpense	695	usd
	us-gaap	Supplies Expense SuppliesExpense	5377	usd
	us-gaap	Supplies Expense SuppliesExpense	2274	usd
CY2023Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	16359	usd
CY2022Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1001	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	27700	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	2185	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	93468	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	190549	usd
	us-gaap	Operating Expenses OperatingExpenses	191175	usd
	us-gaap	Operating Expenses OperatingExpenses	466765	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-93468	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-189445	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-190182	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-465361	usd
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	18311	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8361	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	30307	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	17282	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	101948	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	50000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	149750	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	50000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-105000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-105000	usd
	CLOQ	Loss On Settlement With Officer LossOnSettlementWithOfficer	18086	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-120259	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-163361	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-180057	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-190368	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-213727	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-352806	usd
	us-gaap	Net Income Loss NetIncomeLoss	-370239	usd
	us-gaap	Net Income Loss NetIncomeLoss	-655729	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	120773087	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	120773087	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	86536549	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86536549	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	120939754	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	120939754	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	83403216	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83403216	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-35027	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	97500	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2022Q1	CLOQ	Stock To Be Issued During Period Value StockToBeIssuedDuringPeriodValue	50000	usd
CY2022Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	540000	usd
CY2022Q1	CLOQ	Stock Issued During Period Value Preferred Stock Redeemed For Officers Settlement StockIssuedDuringPeriodValuePreferredStockRedeemedForOfficersSettlement	10	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-302921	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-630458	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	54975	usd
CY2022Q2	CLOQ	Stock Issued During Period Common Stock Issued For Debt StockIssuedDuringPeriodCommonStockIssuedForDebt	140000	usd
CY2022Q2	CLOQ	Stock To Be Issued During Period Value StockToBeIssuedDuringPeriodValue	52186	usd
CY2022Q2	CLOQ	Adjustments To Additional Paid In Capital Stock Retirement Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalStockRetirementOfConvertibleDebt	50000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-352806	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-686103	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	210000	usd
CY2022Q3	CLOQ	Stock To Be Issued During Period Value StockToBeIssuedDuringPeriodValue	50000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	12000	usd
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-490000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-117829	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-41932	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9600	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	49810	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	145000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	60000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-205492	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16986	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	222500	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-156513	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	126973	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	126973	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25250	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	275000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-213727	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-213727	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	213496	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	213496	usd
	us-gaap	Net Income Loss NetIncomeLoss	-370239	usd
	us-gaap	Net Income Loss NetIncomeLoss	-655729	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	149750	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	50000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	289375	usd
	CLOQ	Loss On Settlement With Officer And Director LossOnSettlementWithOfficerAndDirector	18086	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	105000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	25586	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-1051	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-31657	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	313	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	29465	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	14782	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-248267	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-177122	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	306691	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	136610	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-306691	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-136610	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	69250	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	202475	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1225	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	125000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	505000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	574250	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	276250	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19292	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37482	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4067	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54295	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23359	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16813	usd
	us-gaap	Interest Paid Net InterestPaidNet	668	usd
	CLOQ	Beneficial Conversion Feature BeneficialConversionFeature	497500	usd
	us-gaap	Stock Issued1 StockIssued1	100000	usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	490000	usd
	us-gaap	Notes Issued1 NotesIssued1	35000	usd
	CLOQ	Notes Issued NotesIssued	52186	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zeS8ThecDgga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zd3ftNB4Pe28">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the year reported. Actual results may differ from these estimates. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	usd
CY2020	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	321725	usd
CY2023Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	589931	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022Q2	us-gaap	Advertising Expense AdvertisingExpense	0	usd
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	28250000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3000000	shares
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	719	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	589931	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	283240	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7603362	usd
	us-gaap	Net Income Loss NetIncomeLoss	-370239	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	10000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	10	usd
CY2022Q1	us-gaap	Severance Costs1 SeveranceCosts1	50000	usd
CY2022Q1	CLOQ	Gain Loss On Severance Costs GainLossOnSeveranceCosts	18076	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	500000	shares
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50000	usd
CY2022Q1	us-gaap	Litigation Reserve LitigationReserve	490000	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	2600000	shares
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	50000	usd
CY2022	CLOQ	Common Stock Issued For Settlement Of Debt CommonStockIssuedForSettlementOfDebt	2186	usd
	CLOQ	Stock Issued During Period Shares Settlement Of Debt StockIssuedDuringPeriodSharesSettlementOfDebt	2000000	shares
	CLOQ	Debt Instrument Convertible Settlement Method DebtInstrumentConvertibleSettlementMethod	35000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-105000	usd
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	500000	shares
CY2022Q1	us-gaap	Treasury Stock Value Acquired Par Value Method TreasuryStockValueAcquiredParValueMethod	50000	usd
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	10000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	100000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2022Q2	us-gaap	Payments For Rent PaymentsForRent	719	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	35000	usd
CY2023Q2	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent	565000	usd
CY2022Q4	us-gaap	Convertible Subordinated Debt Current ConvertibleSubordinatedDebtCurrent	60000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	150000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	150000	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2022Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	30000	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2022Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	30000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	42500	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	20000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	45000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	30000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	50000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.02
CY2023Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	100000	usd

Files In Submission

Name	View Source	Status
0001493152-23-026787-index-headers.html	Edgar Link	pending
0001493152-23-026787-index.html	Edgar Link	pending
0001493152-23-026787.txt	Edgar Link	pending
0001493152-23-026787-xbrl.zip	Edgar Link	pending
cloq-20230630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cloq-20230630_def.xml	Edgar Link	unprocessable
cloq-20230630_lab.xml	Edgar Link	unprocessable
cloq-20230630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
cloq-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLOQ
CYBERLOQ TECHNOLOGIES, INC. Stock $cloq

2023 Q3 Form 10-Q Financial Statement

#000149315223026787 Filed on August 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLOQ CYBERLOQ TECHNOLOGIES, INC. Stock $cloq

2023 Q3 Form 10-Q Financial Statement

#000149315223026787 Filed on August 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLOQ
CYBERLOQ TECHNOLOGIES, INC. Stock $cloq